))
Dr. Robert Kaufman and the new ValidCare Safety Study on CBD
Manage episode 329557448 series 2965541
Conteúdo fornecido por Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Hemp Industry Episode Resources:
Host: Jonathan Miller
Guest: Dr. Robert Kaufman
Blog: Hemp Legally Speaking
Hemp Industry questions covered in the episode:
- What does the ValidCare study demonstrate about the safety of ingestible CBD?
- What did the study conclude about CBD’s liver toxicity and how does this contrast with studies done on Epidiolex, the CBD drug used by children with rare forms of epilepsy?
- How does the study address concerns about drowsiness and low testosterone?
- Statistically speaking, how strong are the study’s conclusions
- What’s the message that Dr. Kaufman will be sharing with FDA in its upcoming meeting?
51 episódios
Compartilhar
